Cao, W., Chen, H.D., Yu, Y.W., et al., Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020, Chin. Med. J., 2021, vol. 134, no. 7, pp. 783—791.

Article  PubMed  PubMed Central  Google Scholar 

Wang, X., Wang, C., Guan, J., et al., Progress of breast cancer basic research in China, Int. J. Biol. Sci., 2021, vol. 17, no. 8, pp. 2069—2079.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fumagalli, C., Ranghiero, A., Gandini, S., et al., Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses, Breast Cancer Res., 2020, vol. 22, no. 1, р. 107. https://doi.org/10.1186/s13058-020-01345-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anastasiadou, E., Jacob, L.S., and Slack, F.J., Non-coding RNA networks in cancer, Nat. Rev. Cancer, 2018, vol. 18, no. 1, pp. 5—18.

Article  CAS  PubMed  Google Scholar 

Piao, M. and Zhang, L., Knockdown of SNHG16 suppresses the proliferation and induces the apoptosis of leukemia cells via miR‑193a‑5p/CDK8, Int. J. Mol. Med., 2020, vol. 46, no. 3, pp. 1175—1185. https://doi.org/10.3892/ijmm.2020.4671

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paraskevopoulou, M.D. and Hatzigeorgiou, A.G., Analyzing miRNA-lncRNA interactions, Methods Molec. Biol. (Clifton, NJ), 2016, vol. 1402, pp. 271—286.

CAS  Google Scholar 

Rajagopal, T., Talluri, S., Akshaya, R.L., et al., HOTAIR lncRNA: a novel oncogenic propellant in human cancer, Clin. Chim. Acta, 2020, vol. 503, pp. 1—18.

Thin, K.Z., Liu, X., Feng, X., et al., LncRNA-DANCR: a valuable cancer related long non-coding RNA for human cancers, Pathol., Res. Pract., 2018, vol. 214, no. 6, pp. 801—805.

Article  CAS  PubMed  Google Scholar 

Yang, Y., Gao, M., Li, Y., et al., LncRNA CTBP1-AS2 facilitates gastric cancer progression via regulating the miR-139-3p/MMP11 axis, OncoTargets Ther., 2020, vol. 13, pp. 11537—11547.

Article  CAS  Google Scholar 

Cui, K. and Zhu, G., LncRNA CTBP1-AS2 regulates miR-216a/ PTEN to suppress ovarian cancer cell proliferation, J. Ovarian Res., 2020, vol. 13, no. 1, p. 84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soheilyfar, S., Velashjerdi, Z., Sayed Hajizadeh, Y., et al., In vivo and in vitro impact of miR-31 and miR-143 on the suppression of metastasis and invasion in breast cancer, J. BUON, 2018, vol. 23, no. 5, pp. 1290—1296.

PubMed  Google Scholar 

Kong, W., Yang, L., Li, P.P., et al., MiR-381-3p inhibits proliferation, migration and invasion by targeting LRP6 in papillary thyroid carcinoma, Eur. Rev. Med. Pharmacol. Sci., 2018, vol. 22, no. 12, pp. 3804—3811.

CAS  PubMed  Google Scholar 

Yang, X., Ruan, H., Hu, X., et al., miR-381-3p suppresses the proliferation of oral squamous cell carcinoma cells by directly targeting FGFR2, Am. J. Cancer Res., 2017, vol. 7, no. 4, pp. 913—922.

PubMed  PubMed Central  Google Scholar 

Zhang, M., Liu, Y., Teng, P., et al., Differential expression of miR-381-3p in Alzheimer’s disease patients and its role in beta-amyloid-induced neurotoxicity and inflammation, Neuroimmunomodulation, 2021, pp. 1—9.

Rothschild, S.I., Tschan, M.P., Jaggi, R., et al., MicroRNA-381 represses ID1 and is deregulated in lung adenocarcinoma, J. Thorac. Oncol., 2012, vol. 7, no. 7, pp. 1069—1077. https://doi.org/10.1097/JTO.0b013e31824fe976

Article  CAS  PubMed  Google Scholar 

Shi, S.H., Jiang, J., Sun, L., et al., Dynamic regulative biomarker: long noncoding RNA (lncRNA) in metastatic breast cancer, Clin. Lab., 2020, vol. 66, no. 9, р. 191140.

Article  Google Scholar 

Zhang, W., Guan, X., and Tang, J., The long non-coding RNA landscape in triple-negative breast cancer, Cell Proliferation, 2021, vol. 54, no. 2, р. e12966.

Article  CAS  PubMed  Google Scholar 

Zhang, Q., Li, T., Wang, Z., et al., LncRNA NR2F1-AS1 promotes breast cancer angiogenesis through activating IGF-1/IGF-1R/ERK pathway, J. Cell. Mol. Med., 2020, vol. 24, no. 14, pp. 8236—8247.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang, M., Wang, N., Song, P., et al., LncRNA GATA3‑AS1 facilitates tumour progression and immune escape in triple-negative breast cancer through destabilization of GATA3 but stabilization of PD-L1, Cell Proliferation, 2020, vol. 53, no. 9, р. e12855.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, Y., Zong, J., and Zhao, C., LncRNA CTBP1-AS2 promotes proliferation and migration of glioma by modulating miR-370-3p-Wnt7a-mediated epithelial-mesenchymal transition, Biochem. Cell Biol., 2020, vol. 98, no. 6, pp. 661—668.

Article  CAS  PubMed  Google Scholar 

Liu, L.X., Liu, B., Yu, J., et al., SP1-induced upregulation of lncRNA CTBP1-AS2 accelerates the hepatocellular carcinoma tumorigenesis through targeting CEP55 via sponging miR-195-5p, Biochem. Biophys. Res. Commun., 2020, vol. 533, no. 4, pp. 779—785.

Article  CAS  PubMed  Google Scholar 

Zhang, H., Li, J., Shao, W., et al., LncRNA CTBP1-AS2 is upregulated in osteoarthritis and increases the methylation of miR-130a gene to inhibit chondrocyte proliferation, Clin. Rheumatol., 2020, vol. 39, no. 11, pp. 3473—3478.

Article  PubMed  Google Scholar 

Wang, M. and Zhao, H., LncRNA CTBP1-AS2 promotes cell proliferation in hepatocellular carcinoma by regulating the miR-623/Cyclin D1 axis, Cancer Biother. Radiopharm., 2020, vol. 35, no. 10, pp. 765—770.

CAS  PubMed  Google Scholar 

Yang, S., Shi, F., Du, Y., et al., Long non-coding RNA CTBP1-AS2 enhances cervical cancer progression via up-regulation of ZNF217 through sponging miR-3163, Cancer Cell Int., 2020, vol. 20, p. 343.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, G., Wu, B., Zhang, B., et al., LncRNA CTBP1-AS2 alleviates high glucose- induced oxidative stress, ECM accumulation, and inflammation in diabetic nephropathy via miR-155-5p/FOXO1 axis, Biochem. Biophys. Res. Commun., 2020, vol. 532, no. 2, pp. 308—314.

Article  CAS  PubMed  Google Scholar 

Wang, Y., Zhang, C.X., Ge, S.L., et al., CTBP1‑AS2 inhibits proliferation and induces autophagy in ox‑LDL‑stimulated vascular smooth muscle cells by regulating miR‑195‑5p/ATG14, Int. J. Mol. Med., 2020, vol. 46, no. 2, pp. 839—848.

Article  PubMed  Google Scholar 

Yu, Y.Z., Mu, Q., Ren, Q., et al., miR-381-3p suppresses breast cancer progression by inhibition of epithelial-mesenchymal transition, World J. Surg. Oncol., 2021, vol. 19, no. 1, р. 230.

Article  PubMed  PubMed Central  Google Scholar 

Dong, Z. and Zhang, J., miR-381-3p involves in glioma progression by suppressing tumor-promoter factor ANTXR1, Comput. Math. Methods Med., 2021, vol. 2021, р. 4883509.

Article  PubMed  PubMed Central  Google Scholar 

Shang, A., Zhou, C., Bian, G., et al., miR-381-3p restrains cervical cancer progression by downregulating FGF7, Comput. Math. Methods Med., 2019, vol. 120, no. 1, pp. 778—789.

CAS  Google Scholar 

Yi, D., miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1, J. Cell. Biochem., 2019, vol. 43, no. 1, pp. 12—21.

CAS  Google Scholar 

Garcia-Escolano, M., Montoyo-Pujol, Y.G., Ortiz-Martinez, F., et al., ID1 and ID4 are biomarkers of tumor aggressiveness and poor outcome in immunophenotypes of breast cancer, Cancers (Basel), 2021, vol. 13, no. 3, р. 492. https://doi.org/10.3390/cancers13030492

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gumireddy, K., Li, A., Kossenkov, A.V., et al., ID1 promotes breast cancer metastasis by S100A9 regulation, Mol. Cancer Res., 2014, vol. 12, no. 9, pp. 1334—1343.

Article  CAS  PubMed  PubMed Central  Google Scholar